GL1X · GenesisL1 explorer

Research workbench

The structural basis for the reduced activity of the Y226F(Y225F) active site mutant of E. COLI aspartate aminotransferase

Analyse The structural basis for the reduced activity of the Y226F(Y225F) active site… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1ASG
Type
protein
Length
396 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Aspartate aminotransferase
EC
2.6.1.1
UniProt
P00509
Ligands
PLP, MAE
Pockets
7 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 46% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAspartate aminotransferase (EC 2.6.1.1)protein39646% helix, 13% strandP00509

Ligands and binding sites

  • PLP · Pyridoxal-5'-phosphate · ligand · chains A
  • MAE · Maleic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12160.640.8329PLP, MAE
2860.420.7817empty
3690.390.7916empty
4520.360.7914empty
5530.310.7616empty

Modifications

Observed in the structure: 1 cofactor (pyridoxal phosphate Schiff base).

Compared structures

  • 1ASG · The structural basis for the reduced activity of the Y226F(Y225F) active site mutant of… · the same entry in another collection · chain A against A, TM-score 1.00
  • P00509 · AlphaFold monomer V2.0 prediction for aspartate aminotransferase (P00509) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.